Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2008-9-8
pubmed:abstractText
To gain insight into the pathogenesis of hepatic fibrosis related to insulin resistance, we have examined the effects of euglycemic hyperinsulinemia on three matrix metalloproteinases (MMP-2, MMP-9, and MT1-MMP) and on two major tissue inhibitors of MMPs (TIMP-1 and TIMP-2) in liver of insulin-sensitive and insulin-resistant rats. Four hours of insulin infusion (4.8 mU.kg(-1).min(-1)) without or with lipid-heparin infusion (to produce insulin resistance) decreased hepatic MMP-2 mRNA (by RT-PCR), pro-MMP-2, MMP-2, MMP-9, and MT1-MMP (all by Western blots) and the gelatinolytic activity of MMP-2 (by gelatin zymography) by approximately 60-80%. Hyperinsulinemia ( approximately 1.6 mmol/l) increased TIMP-1 and TIMP-2 concentrations (by ELISA) in insulin-sensitive and insulin-resistant rats. Phosphoinositide 3-kinase was activated by insulin in insulin-sensitive rats and inhibited in insulin-resistant rats. Extracellular signal-regulated kinases 1/2 (ERK1/2) were activated by insulin in insulin-sensitive rats and partially inhibited in insulin-resistant rats; c-jun NH(2)-terminal kinase-1 (JNK1), JNK2/3, or p38 MAPK were only activated by lipid but not by insulin. We conclude that hyperinsulinemia, whether or not associated with insulin resistance, shifts the MMP/TIMP balance toward reduction of extracellular matrix degradation and thus may promote the development of hepatic fibrosis.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18664596-10449437, http://linkedlifedata.com/resource/pubmed/commentcorrection/18664596-10708863, http://linkedlifedata.com/resource/pubmed/commentcorrection/18664596-11116048, http://linkedlifedata.com/resource/pubmed/commentcorrection/18664596-11742412, http://linkedlifedata.com/resource/pubmed/commentcorrection/18664596-11961152, http://linkedlifedata.com/resource/pubmed/commentcorrection/18664596-12208863, http://linkedlifedata.com/resource/pubmed/commentcorrection/18664596-14633819, http://linkedlifedata.com/resource/pubmed/commentcorrection/18664596-15040812, http://linkedlifedata.com/resource/pubmed/commentcorrection/18664596-15793228, http://linkedlifedata.com/resource/pubmed/commentcorrection/18664596-16306362, http://linkedlifedata.com/resource/pubmed/commentcorrection/18664596-16854986, http://linkedlifedata.com/resource/pubmed/commentcorrection/18664596-17167774, http://linkedlifedata.com/resource/pubmed/commentcorrection/18664596-17234168, http://linkedlifedata.com/resource/pubmed/commentcorrection/18664596-17383048, http://linkedlifedata.com/resource/pubmed/commentcorrection/18664596-17498511, http://linkedlifedata.com/resource/pubmed/commentcorrection/18664596-17928399, http://linkedlifedata.com/resource/pubmed/commentcorrection/18664596-18025411, http://linkedlifedata.com/resource/pubmed/commentcorrection/18664596-18460333, http://linkedlifedata.com/resource/pubmed/commentcorrection/18664596-3056758, http://linkedlifedata.com/resource/pubmed/commentcorrection/18664596-7601337, http://linkedlifedata.com/resource/pubmed/commentcorrection/18664596-7989608, http://linkedlifedata.com/resource/pubmed/commentcorrection/18664596-8971073, http://linkedlifedata.com/resource/pubmed/commentcorrection/18664596-9076940
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0193-1849
pubmed:author
pubmed:issnType
Print
pubmed:volume
295
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
E692-7
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:18664596-Actins, pubmed-meshheading:18664596-Animals, pubmed-meshheading:18664596-Blotting, Western, pubmed-meshheading:18664596-Glucose Clamp Technique, pubmed-meshheading:18664596-Heparin, pubmed-meshheading:18664596-Hyperinsulinism, pubmed-meshheading:18664596-Immunoprecipitation, pubmed-meshheading:18664596-Insulin, pubmed-meshheading:18664596-Lipid Metabolism, pubmed-meshheading:18664596-Liver, pubmed-meshheading:18664596-Male, pubmed-meshheading:18664596-Matrix Metalloproteinase 2, pubmed-meshheading:18664596-Matrix Metalloproteinase 9, pubmed-meshheading:18664596-Metalloproteases, pubmed-meshheading:18664596-RNA, pubmed-meshheading:18664596-Rats, pubmed-meshheading:18664596-Rats, Sprague-Dawley, pubmed-meshheading:18664596-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:18664596-Tissue Inhibitor of Metalloproteinase-1, pubmed-meshheading:18664596-Tissue Inhibitor of Metalloproteinase-2, pubmed-meshheading:18664596-Tissue Inhibitor of Metalloproteinases
pubmed:year
2008
pubmed:articleTitle
Effects of hyperinsulinemia on hepatic metalloproteinases and their tissue inhibitors.
pubmed:affiliation
Temple University Hospital, Philadelphia, PA 19140, USA. bodengh@tuhs.temple.edu
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural